- Review the mechanism of action of nirsevimab and the studies that brought it to market.
- Review the AAP/CDC criteria for administration and the NorthShore aspirations for delivery and work flows.
- Overview of counseling and anticipatory guidance for families.
09/13/2023 - 8:00am to 9:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Matthew Pellerite, MD